These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 8767482)
1. Cellular metabolism of triglyceride-rich lipoproteins: role of heparan sulfate, lipoprotein lipase and lipoprotein receptors. Sehayek E; Eisenberg S Z Gastroenterol; 1996 Jun; 34 Suppl 3():110-2. PubMed ID: 8767482 [No Abstract] [Full Text] [Related]
2. Interaction of lipoproteins with heparan sulfate proteoglycans and with lipoprotein lipase. Studies by surface plasmon resonance technique. Lookene A; Savonen R; Olivecrona G Biochemistry; 1997 Apr; 36(17):5267-75. PubMed ID: 9136889 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. Williams KJ; Fless GM; Petrie KA; Snyder ML; Brocia RW; Swenson TL J Biol Chem; 1992 Jul; 267(19):13284-92. PubMed ID: 1320015 [TBL] [Abstract][Full Text] [Related]
4. [Metabolism of chylomicrons and very low density lipoproteins]. Windler E Klin Wochenschr; 1990; 68 Suppl 22():19-22. PubMed ID: 2087074 [TBL] [Abstract][Full Text] [Related]
5. Cellular metabolism of apoprotein-B containing lipoproteins: the role of apoproteins, heparan sulfate and cellular receptors. Sehayek E Isr J Med Sci; 1996 Jun; 32(6):445-8. PubMed ID: 8682649 [No Abstract] [Full Text] [Related]
6. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes. Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863 [TBL] [Abstract][Full Text] [Related]
7. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism? Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025 [TBL] [Abstract][Full Text] [Related]
8. Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway. Karpe F; Hultin M J Lipid Res; 1995 Jul; 36(7):1557-66. PubMed ID: 7595079 [TBL] [Abstract][Full Text] [Related]
9. The role of lipases and LRP in the catabolism of triglyceride-rich lipoproteins. Beisiegel U; Krapp A; Weber W; Olivecrona G; Gliemann J Z Gastroenterol; 1996 Jun; 34 Suppl 3():108-9. PubMed ID: 8767481 [TBL] [Abstract][Full Text] [Related]
10. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus. Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975 [TBL] [Abstract][Full Text] [Related]
11. Insulin and non-esterified fatty acid relations to alimentary lipaemia and plasma concentrations of postprandial triglyceride-rich lipoproteins in healthy middle-aged men. Boquist S; Hamsten A; Karpe F; Ruotolo G Diabetologia; 2000 Feb; 43(2):185-93. PubMed ID: 10753040 [TBL] [Abstract][Full Text] [Related]
12. Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix. Eisenberg S; Sehayek E; Olivecrona T; Vlodavsky I J Clin Invest; 1992 Nov; 90(5):2013-21. PubMed ID: 1430223 [TBL] [Abstract][Full Text] [Related]
13. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo. Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467 [TBL] [Abstract][Full Text] [Related]
14. Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection. Andréo U; Maillard P; Kalinina O; Walic M; Meurs E; Martinot M; Marcellin P; Budkowska A Cell Microbiol; 2007 Oct; 9(10):2445-56. PubMed ID: 17517063 [TBL] [Abstract][Full Text] [Related]
15. In vivo studies of VLDL metabolism and LDL heterogeneity. Demant T; Packard C Eur Heart J; 1998 Jul; 19 Suppl H():H7-10. PubMed ID: 9717058 [TBL] [Abstract][Full Text] [Related]
16. Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans. Stalenhoef AF; Malloy MJ; Kane JP; Havel RJ Proc Natl Acad Sci U S A; 1984 Mar; 81(6):1839-43. PubMed ID: 6584917 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men. Chan DC; Watts GF; Ng TW; Uchida Y; Sakai N; Yamashita S; Barrett PH Clin Biochem; 2005 Sep; 38(9):806-12. PubMed ID: 15992790 [TBL] [Abstract][Full Text] [Related]